ACLS Stock Recent News

Axcelis's Power Device segment, driven by SiC, has shown impressive growth, becoming the largest revenue contributor with an average growth rate of 61.7% from 2021 to 2024. Despite the overall semiconductor market's modest growth, Axcelis's competitive strengths in SiC devices have significantly outpaced the market, contributing to its robust performance. Based on a P/S valuation and projected revenue growth, we rate Axcelis as a Strong Buy.

BEVERLY, Mass. , Jan. 6, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that management will participate in the 27th Annual Needham Growth Conference, taking place at the Lotte New York Palace Hotel on January 14-17, 2025.

In the most recent trading session, Axcelis Technologies (ACLS) closed at $69.47, indicating a +0.42% shift from the previous trading day.

BEVERLY, Mass. , Dec. 3, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that it will showcase its Purion™ and GSD Ovation™ Series of ion implanters at the SEMICON Japan 2024 exhibition.

Investors need to pay close attention to Axcelis Technologies (ACLS) stock based on the movements in the options market lately.

BEVERLY, Mass. , Nov. 19, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that management will participate in the following investor conferences: 2024 Wells Fargo TMT Summit, taking place at the Terranea Resort in Rancho Palos Verdes, CA on December 3 and 4, 2024.

Axcelis Technologies, Inc. (NASDAQ:ACLS ) Q3 2024 Earnings Conference Call November 7, 2024 8:30 AM ET Company Participants David Ryzhik - Senior Vice President of Investor Relations and Corporate Strategy Russell Low - President and Chief Executive Officer James Coogan - Executive Vice President and Chief Financial Officer Conference Call Participants Craig Ellis - B. Riley Securities Jack Egan - Charter Equity Research Ross Cole - Needham and Company LLC Tom Diffely - D.A.

Axcelis Technologies (ACLS) came out with quarterly earnings of $1.49 per share, beating the Zacks Consensus Estimate of $1.43 per share. This compares to earnings of $1.99 per share a year ago.

Revenue of $256.6 million Operating margin of 18.3% Diluted earnings per share of $1.49 BEVERLY, Mass. , Nov. 6, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the third quarter ended September 30, 2024.

ACLS' third-quarter performance is likely to have benefited from solid demand for ion implantation systems, especially in the silicon carbide space.